Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
The current price of Johnson & Johnson in the market is 2 077,39 kr, with a 24-hour trading volume of 17,43B kr. The asset's market cap is 5T kr, after moving 0.04% in the last day.
Tokenized Johnson & Johnson is trading at 2 082,04 kr, with a tokenized market cap of 8,32M kr and a 24-hour trading volume of 14,45K kr. The tokenized asset has moved 0.47% in the past 24 hours.